N.B.: This evaluation refers to 2020 and is outdated: display the current evaluation.

GSK PLCCompany logo

United Kingdom (GB)

OpenCorporation rating: 57.63 on 100

Ranking 2020: 84 on 602 companies


Primary NACE classification:
Manufacture of pharmaceutical preparations (2120)

Company description

This company, formerly known as Glaxo Smithkline plc, is a world leading research-based pharmaceutical company which manufactures various pharmaceutical products. Headquartered in Brentford, United Kingdom, the company has its operations based in the United States. The name of the company evolved after Glaxo Wellcome and SmithKline Beecham merged in January 2000-the date it was founded. The company produces medicines that treat six major disease areas - asthma, virus control, infections, mental health, diabetes, and digestive conditions. In addition, it is a leader in the important area of vaccines and is developing new treatments for cancer. The company's products and services are grouped into prescription medicines, vaccines, and consumer healthcare, which include brands such as Panadol, Aquafresh, Lucozade, Ribena, Horlicks, Nicorette/Niquitin, Gaviscon, and Macleans. The company is one of the largest collaborators in the pharmaceutical industry in the world. It works with more than 50 academic institutions and other pharmaceutical and biotechnology companies. It provides a wide range of pharmaceutical products to address many of the world's major healthcare needs. The company also has a leadership in four major therapeutic areas: anti-infectives, central nervous systems, respiratory, and gastrointestinal/metabolic.The company is committed to fighting filariasis through its membership of the Global Alliance to Eliminate Lymphatic Filariasis. It is active in 70 countries in Europe, North and South America, Caricam, Andina, Asia and Australasia, Southeast Asia, Africa, and the Middle East.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.

Indicators

The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)
ratings 2019
53.3
53.3
93
93
53.4
62.1
43
68.4
51.2
51.2
9.7
9.7
48
61.4
60
46.4
50.4

HQ and subsidiaries

GSK PLC
loading subsidiaries

* The position of map pins may not reflect the exact location

Latest news about gsk plc

9 March 2020 - 12:00

35 vaccini candidati contro la Covid-19

Ci sarebbero 35 i vaccini candidati contro la Covid-19 in tutto il mondo. Qualche settimana fa erano dieci in meno. Tuttavia molti studi sono ancora in fase preclinica e i dettagli sono ancora poco chiari. La corsa all’oro del 2020, comunque, è contrassegnata anche a colpi mediatici piuttosto rilevanti dato che sempre più aziende annunciano lavori sul vaccino contro il nuovo coronavirus o, come nel caso dell’azienda americana Moderna (una delle prima ad essersi messa al lavoro) di essere vicino alla soluzione.

9 March 2020 - 12:00

These nine companies are working on coronavirus treatments or vaccines — here’s where things stand

The list includes Gilead Sciences Inc. and Moderna Inc. along with smaller biotechs

In the U.S., the companies that are initiating development have received funding from two organizations: the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Some companies have received funding from Coalition for Epidemic Preparedness Innovations (CEPI), a global organization based in Oslo. Other companies are funding trials by themselves or through partnerships with other life sciences companies.

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of GSK PLC you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

Permament links

The link below will always open the 2020 evaluation:

2020: https://www.opencorporation.org/en/ranking/glaxosmithkline-plc/2020    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/glaxosmithkline-plc/last    url copied